Condition (MeSH)
Dystonic Disorders
ClinicalTrials.gov lists 97 trials for Dystonic Disorders or a narrower condition beneath it. National Institute of Neurological Disorders and Stroke (NINDS) has the most among industry and government lead sponsors, with 33.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase (log scale)
92 of the 97 trials are tagged with Dystonic Disorders itself; the rest are tagged with a narrower condition beneath it.
When did Dystonic Disorders trials start? (27)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 2
- Phase 2/3
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 8
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2025 | 6 |
| 2024 | 3 |
| 2023 | 5 |
| 2022 | 1 |
| 2021 | 5 |
| 2020 | 4 |
| 2019 | 3 |
| 2018 | 6 |
| 2017 | 8 |
Showing 10 of 27 earlier years.
No forecast is made for this condition: it averages 3.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Prediction, not a registry value: median of 36 months from start to primary completion across 7 trials still running at the 2026-10-09 snapshot; registered median of 35 months across 41 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Dystonic Disorders trials in? (8)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 8 |
| Phase 1/2 | 5 |
| Phase 2 | 8 |
| Phase 2/3 | 2 |
| Phase 3 | 1 |
| Phase 4 | 3 |
| Not applicable | 20 |
| Observational | 50 |
How many Dystonic Disorders trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 17 |
| Active, not recruiting | 3 |
| Completed | 52 |
| Terminated | 10 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Dystonic Disorders trials? (6)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| National Institute of Neurological Disorders and Stroke (NINDS) | 33 |
| Fondation Ophtalmologique Adolphe de Rothschild | 4 |
| Institut National de la Santé Et de la Recherche Médicale, France | 2 |
| Vima Therapeutics | 2 |
| Abbott Medical Devices | 1 |
Showing 5 of 6 sponsors.
Interventions as named in the registry (15)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Transcranial Magnetic Stimulation | 4 |
| type A botulinum toxin | 3 |
| Sham rTMS | 2 |
| Wumeiwan Jiawei Fang | 1 |
| VIM0423 | 1 |
Showing 5 of 15 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Dystonic Disorders trials report? (5)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Automobile accident | 1 | 1 |
| Blepharitis | 1 | 1 |
| Muscle Atrophy | 1 | 1 |
| Severe Weakness | 1 | 1 |
| Suicidal depression | 0 | 1 |
Which publications cover Dystonic Disorders? (145)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Motor network reorganization associated with rTMS-induced writing improvement in writer's cramp dystonia. | Brain stimulation | 2025 | Yes |
| Subthalamic deep brain stimulation in isolated generalised or segmental dystonia (RELAX Study): a multicentre, randomised, double-blind, controlled trial. | Journal of neurology, neurosurgery, and psychiatry | 2025 | Yes |
| Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia: ASPEN-1 Phase 3 Randomized Controlled Trial. | Neurology | 2024 | Yes |
| Spatiotemporal Gait Differences before and after Botulinum Toxin in People with Focal Dystonia: A Pilot Study. | Movement disorders clinical practice | 2024 | Yes |
| Suitability of Automated Writing Measures for Clinical Trial Outcome in Writer's Cramp. | Movement disorders : official journal of the Movement Disorder Society | 2023 | Yes |
Showing 5 of 145 publications.
Sub-conditions in MeSH (2)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence and rare-disease identity.